Pfizer CEO predicts coronavirus oral antiviral pill ready ‘by end of year’
Albert Bourla, chairman and CEO of Pfizer, said Tuesday he hopes the company’s coronavirus oral antiviral therapeutic in early-stage trials will be ready by the end of the year. “…If all goes well and we implement the same speed that we did so far and we are and if regulators also do the same and they are,… Read More »